Sandercock Brett 4
4 · RESMED INC · Filed Jan 5, 2026
Insider Transaction Report
Form 4
RESMED INCRMD
Sandercock Brett
Chief Financial Officer
Transactions
- Sale
ResMed Common Stock
2026-01-02$241.75/sh−1,000$241,750→ 86,495 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.